Addressing heart disease risk in people with HIV in Nigeria
Official title: Addressing CVD Multimorbidity in Patients Living with HIV in Nigeria
Funded at New York University School of Medicine · NIH-11328379 · Data updated 2026-11-12
A patient-friendly plan to help people living with HIV in Nigeria better manage heart disease risk by integrating diabetes and high blood pressure care into HIV clinics.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 1, 2026 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $510,538 |
| NIH project number | 1R61HL184905-01 |
| Project ID | NIH-11328379 on NIH RePORTER |
Who could benefit from this research
✓Could help
People living with HIV in Nigeria who also have or are at risk for diabetes and hypertension and receive care at primary health centers.
✕Less likely to help
Individuals without HIV or without cardiovascular risk factors may not directly benefit from this specific intervention.
What this research studies
This project uses a proven care framework to weave diabetes and high blood pressure management into regular HIV care at primary clinics in Lagos, Nigeria. It builds on a successful prior trial showing safer blood pressure control when HTN care is shared with HIV services, and tests the addition of diabetes care within the same system. The team will apply a chronic care approach and HEARTS recommendations to support clinicians, patients, and clinic systems in delivering integrated, ongoing care. The study emphasizes real-world implementation in primary care settings and measures both how well the care is delivered and its impact on health.
Why it matters
Potential benefit: If successful, the approach could reduce blood pressure and blood sugar problems among people living with HIV, lowering their risk of cardiovascular disease.
How similar studies have gone: Prior implementation work showed meaningful blood pressure reduction when HTN care was integrated into HIV services, supporting the potential for similar benefits with DM and HTN integration.
Where this research is happening
-
New York University School of Medicine
New York, United States Active
Researchers
- Principal investigator: Ogedegbe, Olugbenga G. — New York University School of Medicine
- Study coordinator: Ogedegbe, Olugbenga G.
Related research
Other NIH-funded projects on the same topics.
-
Integrated Heart Health: A HEARTS-based approach to hypertension and diabetes in Guatemala
A study tests a team-based, stepwise care model to improve blood pressure and blood sugar control for people with both hypertension and diabetes in Guatemala.
-
M-CaRE: Mobile clinics and a smart heart-lung care tool for multimorbidity
A mobile, multilingual tool plus community health workers will help screen and manage high blood pressure and COPD in diverse adult patients, especially in underserved areas.
-
Alcohol and HIV interaction driving lung and liver damage through cell signals
This program explores how alcohol worsens lung and liver problems in people with HIV by affecting cell signals that travel between organs.
-
Addressing heart disease risk with HIV care in Nigeria
A plan to bring heart-disease prevention and treatment into HIV care for people living with HIV in Nigeria.
-
Understanding how care teams connect to better care for older adults with ADRD and multiple health problems
This grant tests how the way clinicians work together (their network) affects care quality and outcomes for older adults with Alzheimer's or related dementias and multiple health issues.
-
MADIVA: Using digital tools to study multimorbidity in Africa
A hosted research program in Africa is building advanced data resources and language-model based tools to study how multiple diseases and aging affect people in rural South Africa and urban Kenya.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.